Sales rights transfer for moxifloxacin (AVELOX) in Japan

Bayer Yakuhin, Ltd. (Bayer) and Shionogi & Co., Ltd. (Shionogi) have reached an agreement to transfer to Bayer the sales rights of the new quinolone oral antibiotic Avelox ® tablets 400 mg (generic name: moxifloxacin HCL) currently sold by Shionogi in Japan. The transfer will take effect on 1 July 2010.

Source : Oral Antibiotic Avelox®: Sales Rights Transfer